These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 21893399)
21. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery. Thompson CJ; Tetley L; Cheng WP Int J Pharm; 2010 Jan; 383(1-2):216-27. PubMed ID: 19766178 [TBL] [Abstract][Full Text] [Related]
22. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
23. Hybrid liposomes composed of amphiphilic chitosan and phospholipid: Preparation, stability and bioavailability as a carrier for curcumin. Peng S; Zou L; Liu W; Li Z; Liu W; Hu X; Chen X; Liu C Carbohydr Polym; 2017 Jan; 156():322-332. PubMed ID: 27842829 [TBL] [Abstract][Full Text] [Related]
24. Oral delivery of insulin using chitosan capsules cross-linked with phytic acid. Lee H; Jeong C; Ghafoor K; Cho S; Park J Biomed Mater Eng; 2011; 21(1):25-36. PubMed ID: 21537061 [TBL] [Abstract][Full Text] [Related]
25. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Akhtar F; Rizvi MM; Kar SK Biotechnol Adv; 2012; 30(1):310-20. PubMed ID: 21619927 [TBL] [Abstract][Full Text] [Related]
26. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications. Sahni JK; Chopra S; Ahmad FJ; Khar RK J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113 [TBL] [Abstract][Full Text] [Related]
27. The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery. Thompson CJ; Tetley L; Uchegbu IF; Cheng WP Int J Pharm; 2009 Jul; 376(1-2):46-55. PubMed ID: 19375489 [TBL] [Abstract][Full Text] [Related]
28. Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles. Zhang J; Zhu X; Jin Y; Shan W; Huang Y Mol Pharm; 2014 May; 11(5):1520-32. PubMed ID: 24673570 [TBL] [Abstract][Full Text] [Related]
29. Effect of high-pressure homogenization and stabilizers on the physicochemical properties of curcumin-loaded glycerol monooleate/chitosan nanostructures. Mistry PH; Mohapatra SK; Dash AK Nanomedicine (Lond); 2012 Dec; 7(12):1863-76. PubMed ID: 22709346 [TBL] [Abstract][Full Text] [Related]
30. ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug. Lee JH; Sahu A; Choi WI; Lee JY; Tae G Biomaterials; 2016 Oct; 103():160-169. PubMed ID: 27380442 [TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439 [TBL] [Abstract][Full Text] [Related]
32. Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(L-lactic acid): protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity. Simon M; Behrens I; Dailey LA; Wittmar M; Kissel T Eur J Pharm Biopharm; 2007 May; 66(2):165-72. PubMed ID: 17150341 [TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evaluation of a novel oral insulin formulation. Ma EL; Ma H; Liu Z; Zheng GX; Duan MX Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747 [TBL] [Abstract][Full Text] [Related]
34. In vitro biocompatibility and release of curcumin from curcumin microcomplex-loaded chitosan scaffold. Amirthalingam M; Kasinathan N; Mutalik S; Udupa N J Microencapsul; 2015; 32(4):364-71. PubMed ID: 25893983 [TBL] [Abstract][Full Text] [Related]
35. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Sajeesh S; Sharma CP Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846 [TBL] [Abstract][Full Text] [Related]
36. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption. Yuan H; Lu LJ; Du YZ; Hu FQ Mol Pharm; 2011 Feb; 8(1):225-38. PubMed ID: 21138243 [TBL] [Abstract][Full Text] [Related]
37. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Wahlang B; Pawar YB; Bansal AK Eur J Pharm Biopharm; 2011 Feb; 77(2):275-82. PubMed ID: 21147222 [TBL] [Abstract][Full Text] [Related]